课题基金 / 基金详情

Division of Cancer Tratment and DIagnosis- Operational Task Order

Division of Cancer Tratment and DIagnosis- Operational Task Order
癌症治疗和诊断科-操作任务顺序
批准号:
10199839
负责人:
LEONARD FREEDMAND
金额:
$868.42万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-08-31 至 2020-08-30

项目摘要

项目成果

LEONARD FREEDMAND的其他基金

相似基金

相关文献

中文摘要
翻译
癌症治疗和诊断司(DCTD)通过加快新制剂、生物标志物、成像测试和其他诊断和治疗干预(放射、手术、免疫治疗)的初始和后续大规模测试,支持癌症新诊断和治疗方法的开发。在DCTD内,八个主要项目和一个患者诊所合作,将独特的分子、诊断测试和治疗干预从实验室平台带到患者床边。该合同支持的活动包括:天然产物的分离和评价;分子药理学;化合物文库的高通量筛选;临床试验中药效学标志物和药代动力学分析的开发和利用;药物毒理学研究;信息系统、技术和数据科学;药物发现;放射化学和放射性药物生产;临床试验图像、体外和体内翻译研究的存档;天然产物、患者来源的异种移植、肿瘤和生物抗癌药物的存储库支持;生物制药生产设施;医疗作家;为在NIH临床中心进行的临床试验、与生物制药公司合作的相关研究提供的护理支持服务;对精确药物试验的支持;先进的基因组学能力支持临床前模型和临床试验中的肿瘤评估;NCI资助的临床试验的患者生物库;纳米技术表征和评估。
英文摘要
The Division of Cancer Treatment and Diagnosis (DCTD) supports the development of novel diagnostic and therapeutic approaches for cancer by expediting the initial and subsequent large-scale testing of new agents, biomarkers, imaging tests, and other diagnostic and therapeutic interventions (radiation, surgery, immunotherapy) in patients. Within DCTD, eight major programs and a patient clinic work together to bring unique molecules, diagnostic tests, and therapeutic interventions from the laboratory bench to the patient bedside. Activities supported under this contract include: isolation and evaluation of natural products; molecular pharmacology; high-throughput screening of compound libraries; pharmacodynamic marker and pharmacokinetic assay development and utilization in clinical trials; drug toxicology research; information systems, technologies, and data science; drug discovery; radiochemistry and radioactive drug production; archival of clinical trial images, in vitro and in vivo translational research; repository support for natural products, patient-derived xenografts, tumors and biologic anti-cancer agents; a biopharmaceutical production facility; medical writers; nursing support services for clinical trials performed in the NIH Clinical Center, correlative studies in collaboration with biopharmaceutical companies; support for precision medicine trials; advanced genomics capabilities supporting tumor evaluation in pre-clinical models and clinical trials; patient biorepositories for NCI-funded clinical trials; nanotechnology characterization and evaluation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DCP - Cancer Prevention Phase 0/I/II Cancer Prevention Clinical Trials Program (Consortia) BioRepository
  • 批准号:
    10199869
  • 项目类别:
  • 资助金额:
    $3.99万
  • 财政年份:
    2019
  • 负责人:
    LEONARD FREEDMAND
  • 依托单位:
Repository for the Family Investigation of Nephropathy & Diabetes
  • 批准号:
    10043394
  • 项目类别:
  • 资助金额:
    $4.12万
  • 财政年份:
    2019
  • 负责人:
    LEONARD FREEDMAND
  • 依托单位:
TAS::75 0849::TAS INCREMENTAL FUNDING
  • 批准号:
    10038552
  • 项目类别:
  • 资助金额:
    $4.87万
  • 财政年份:
    2019
  • 负责人:
    LEONARD FREEDMAND
  • 依托单位:
Strategic Scientific Pilot Support
  • 批准号:
    10040640
  • 项目类别:
  • 资助金额:
    $168.64万
  • 财政年份:
    2019
  • 负责人:
    LEONARD FREEDMAND
  • 依托单位:
海外基金